{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:58:28Z","timestamp":1760057908688,"version":"build-2065373602"},"reference-count":51,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["1R01CA236814-01A1","U54CA272691-01","I01 BX006235","LLS 6702-25","R37 AA18282"],"award-info":[{"award-number":["1R01CA236814-01A1","U54CA272691-01","I01 BX006235","LLS 6702-25","R37 AA18282"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Veterans Administration","award":["1R01CA236814-01A1","U54CA272691-01","I01 BX006235","LLS 6702-25","R37 AA18282"],"award-info":[{"award-number":["1R01CA236814-01A1","U54CA272691-01","I01 BX006235","LLS 6702-25","R37 AA18282"]}]},{"name":"Leukemia Lymphoma Society","award":["1R01CA236814-01A1","U54CA272691-01","I01 BX006235","LLS 6702-25","R37 AA18282"],"award-info":[{"award-number":["1R01CA236814-01A1","U54CA272691-01","I01 BX006235","LLS 6702-25","R37 AA18282"]}]},{"name":"Paula and Rodger Riney Foundation","award":["1R01CA236814-01A1","U54CA272691-01","I01 BX006235","LLS 6702-25","R37 AA18282"],"award-info":[{"award-number":["1R01CA236814-01A1","U54CA272691-01","I01 BX006235","LLS 6702-25","R37 AA18282"]}]},{"name":"Myeloma Solution Fund","award":["1R01CA236814-01A1","U54CA272691-01","I01 BX006235","LLS 6702-25","R37 AA18282"],"award-info":[{"award-number":["1R01CA236814-01A1","U54CA272691-01","I01 BX006235","LLS 6702-25","R37 AA18282"]}]},{"name":"UAMS Winthrop P. Rockefeller Cancer Institute (WRCRI) Fund","award":["1R01CA236814-01A1","U54CA272691-01","I01 BX006235","LLS 6702-25","R37 AA18282"],"award-info":[{"award-number":["1R01CA236814-01A1","U54CA272691-01","I01 BX006235","LLS 6702-25","R37 AA18282"]}]},{"name":"National Institute of Health","award":["1R01CA236814-01A1","U54CA272691-01","I01 BX006235","LLS 6702-25","R37 AA18282"],"award-info":[{"award-number":["1R01CA236814-01A1","U54CA272691-01","I01 BX006235","LLS 6702-25","R37 AA18282"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Multiple myeloma (MM) is a malignancy of terminally differentiated B-cells that is localized primarily in the bone marrow (BM) but also can be present in peripheral blood and tissue\/organs [...]<\/jats:p>","DOI":"10.3390\/cancers17050833","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T10:12:33Z","timestamp":1740737553000},"page":"833","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cystatin M\/E Ameliorates Multiple Myeloma-Induced Hyper Osteolytic Bone Resorption"],"prefix":"10.3390","volume":"17","author":[{"given":"Dongzheng","family":"Gai","sequence":"first","affiliation":[{"name":"Myeloma Center, Winthrop P. Rockefeller Cancer Institute, Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Perry C.","family":"Caviness","sequence":"additional","affiliation":[{"name":"Arkansas Children\u2019s Nutrition Center, Little Rock, AR 72205, USA"},{"name":"Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oxana P.","family":"Lazarenko","sequence":"additional","affiliation":[{"name":"Arkansas Children\u2019s Nutrition Center, Little Rock, AR 72205, USA"},{"name":"Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer F.","family":"Chen","sequence":"additional","affiliation":[{"name":"Undergraduate Pre-Medical Program, University of Arkansas at Fayetteville, Fayetteville, AR 72701, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher E.","family":"Randolph","sequence":"additional","affiliation":[{"name":"Center for Translational Pediatric Research, Arkansas Children\u2019s Research Institute, Little Rock, AR 72202, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zijun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Myeloma Center, Winthrop P. Rockefeller Cancer Institute, Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7877-9622","authenticated-orcid":false,"given":"Yan","family":"Cheng","sequence":"additional","affiliation":[{"name":"Myeloma Center, Winthrop P. Rockefeller Cancer Institute, Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumou","family":"Sun","sequence":"additional","affiliation":[{"name":"Myeloma Center, Winthrop P. Rockefeller Cancer Institute, Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongwei","family":"Xu","sequence":"additional","affiliation":[{"name":"Myeloma Center, Winthrop P. Rockefeller Cancer Institute, Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4126-3750","authenticated-orcid":false,"given":"Michael L.","family":"Blackburn","sequence":"additional","affiliation":[{"name":"Arkansas Children\u2019s Nutrition Center, Little Rock, AR 72205, USA"},{"name":"Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guido","family":"Tricot","sequence":"additional","affiliation":[{"name":"Myeloma Center, Winthrop P. Rockefeller Cancer Institute, Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"John D.","family":"Shaughnessy","sequence":"additional","affiliation":[{"name":"Myeloma Center, Winthrop P. Rockefeller Cancer Institute, Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Ran","family":"Chen","sequence":"additional","affiliation":[{"name":"Arkansas Children\u2019s Nutrition Center, Little Rock, AR 72205, USA"},{"name":"Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5417-2973","authenticated-orcid":false,"given":"Fenghuang","family":"Zhan","sequence":"additional","affiliation":[{"name":"Myeloma Center, Winthrop P. Rockefeller Cancer Institute, Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,2,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"17046","DOI":"10.1038\/nrdp.2017.46","article-title":"Multiple myeloma","volume":"3","author":"Kumar","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/leu.2008.336","article-title":"Pathogenesis of myeloma bone disease","volume":"23","author":"Roodman","year":"2009","journal-title":"Leukemia"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1056\/NEJMoa030847","article-title":"The role of the wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma","volume":"349","author":"Tian","year":"2003","journal-title":"N. Engl. J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1182\/blood-2018-11-852459","article-title":"Myeloma bone disease: From biology findings to treatment approaches","volume":"133","author":"Terpos","year":"2019","journal-title":"Blood"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"5829","DOI":"10.1158\/1078-0432.CCR-09-0426","article-title":"High-dose zoledronic acid impacts bone remodeling with effects on osteoblastic lineage and bone mechanical properties","volume":"15","author":"Pozzi","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa030897","article-title":"Ten Years\u2019 Experience with alendronate for osteoporosis in postmenopausal women","volume":"350","author":"Bone","year":"2004","journal-title":"N. Engl. J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/annonc\/mdm442","article-title":"Guidance on the use of bisphosphonates in solid tumours: Recommendations of an international expert panel","volume":"19","author":"Aapro","year":"2008","journal-title":"Ann. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1006\/bbrc.1999.1499","article-title":"Farnesyl pyrophosphate synthase is the molecular target of nitrogen-containing bisphosphonates","volume":"264","author":"Pieterman","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1359\/jbmr.060118","article-title":"Inhibition of protein prenylation by bisphosphonates causes sustained activation of Rac, CDC42, and Rho GTPases","volume":"21","author":"Dunford","year":"2006","journal-title":"J. Bone Miner. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3892\/mmr.2015.4627","article-title":"Dose-dependent inhibitory effects of zoledronic acid on osteoblast viability and function in vitro","volume":"13","author":"Huang","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1158\/1078-0432.CCR-07-1430","article-title":"Clinical, radiographic, and biochemical characterization of multiple myeloma patients with osteonecrosis of the jaw","volume":"14","author":"Raje","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1182\/blood-2012-10-435750","article-title":"Optimal use of bisphosphonates in patients with multiple myeloma","volume":"121","author":"Terpos","year":"2013","journal-title":"Blood"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41408-017-0037-4","article-title":"Pathogenesis of bone disease in multiple myeloma: From bench to bedside","volume":"8","author":"Terpos","year":"2018","journal-title":"Blood Cancer J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/jbmr.3606","article-title":"Preventing and repairing myeloma bone disease by combining conventional antiresorptive treatment with a bone anabolic agent in murine models","volume":"34","author":"Tazzyman","year":"2019","journal-title":"JBMR"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.bone.2016.07.007","article-title":"Combined treatment with a transforming growth factor beta inhibitor (1D11) and bortezomib improves bone architecture in a mouse model of myeloma-induced bone disease","volume":"91","author":"Nyman","year":"2016","journal-title":"Bone"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"159527","DOI":"10.1172\/JCI159527","article-title":"CST6 suppresses osteolytic bone disease in multiple myeloma by blocking osteoclast differentiation","volume":"132","author":"Gai","year":"2022","journal-title":"J. Clin. Investig."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"9821","DOI":"10.7150\/thno.62187","article-title":"CST6 protein and peptides inhibit breast cancer bone metastasis by suppressing CTSB activity and osteoclastogenesis","volume":"11","author":"Li","year":"2021","journal-title":"Theranostics"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"R100","DOI":"10.1186\/bcr2783","article-title":"Cystatin M loss is associated with the losses of estrogen receptor, progesterone receptor, and HER4 in invasive breast cancer","volume":"12","author":"Ko","year":"2010","journal-title":"Breast Cancer Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1038\/s42255-020-00318-y","article-title":"Stepwise cell fate decision pathways during osteoclastogenesis at single-cell resolution","volume":"2","author":"Tsukasaki","year":"2020","journal-title":"Nat. Metab."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"8","DOI":"10.12659\/MSMBR.902285","article-title":"M3 macrophages stop division of tumor cells in vitro and extend survival of mice with ehrlich ascites carcinoma","volume":"23","author":"Kalish","year":"2017","journal-title":"Med. Sci. Monit. Basic Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.3892\/ijmm.2012.1114","article-title":"Chondrogenic ATDC5 cells: An optimized model for rapid and physiological matrix mineralization","volume":"30","author":"Newton","year":"2012","journal-title":"Int. J. Mol. Med."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Tai, T.W., Chen, C.Y., Su, F.C., Tu, Y.K., Tsai, T.T., Lin, C.F., and Jou, I.M. (2017). Reactive oxygen species are required for zoledronic acid-induced apoptosis in osteoclast precursors and mature osteoclast-like cells. Sci. Rep., 7.","DOI":"10.1038\/srep44245"},{"key":"ref_23","first-page":"10452","article-title":"Apoptotic effect of matrix metalloproteinases 9 in the development of diabetic retinopathy","volume":"8","author":"Chen","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"9610","DOI":"10.1074\/jbc.M411092200","article-title":"Polymorphisms in human organic anion-transporting polypeptide 1A2 (OATP1A2): Implications for altered drug disposition and central nervous system drug entry","volume":"280","author":"Lee","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1152\/ajpcell.00436.2008","article-title":"Mechanisms of pH-gradient driven transport mediated by organic anion polypeptide transporters","volume":"296","author":"Leuthold","year":"2009","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1210\/en.2014-1337","article-title":"Minireview: SLCO and ABC transporters: A role for steroid transport in prostate cancer progression","volume":"155","author":"Cho","year":"2014","journal-title":"Endocrinology"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Norton, A., Thieu, K., Baumann, C.W., Lowe, D.A., and Mansky, K.C. (2022). Estrogen regulation of myokines that enhance osteoclast differentiation and activity. Sci. Rep., 12.","DOI":"10.1038\/s41598-022-19438-4"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Streicher, C., Heyny, A., Andrukhova, O., Haigl, B., Slavic, S., Sch\u00fcler, C., Kollman, K., Kanter, I., Sexl, V., and Kleiter, M. (2017). Estrogen regulates bone turnover by targeting RANKL expression in bone lining cells. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-06614-0"},{"key":"ref_29","first-page":"1498","article-title":"Estrogen enhances human osteoblast survival and function via promotion of autophagy","volume":"1866","author":"Gavali","year":"2019","journal-title":"BBA\u2014Mol. Cell Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.mce.2010.05.004","article-title":"Estrogen and glucocorticoid regulate osteoblast differentiation through the interaction of bone morphogenetic protein-2 and tumor necrosis factor-\u03b1 in C2C12 cells","volume":"325","author":"Matsumoto","year":"2010","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.2174\/1871530320666200604160614","article-title":"Are oxidative stress and inflammation mediators of bone loss due to estrogen deficiency? A review of current evidence","volume":"20","author":"Mohamad","year":"2020","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s00223-010-9393-9","article-title":"Association of oxidative stress with postmenopausal osteoporosis and the effects of hydrogen peroxide on osteoclast formation in human bone marrow cell cultures","volume":"87","author":"Baek","year":"2010","journal-title":"Calcif. Tissue Int."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1128\/IAI.00076-11","article-title":"Estradiol and progesterone strongly inhibit the innate immune response of mononuclear cells in newborns","volume":"79","author":"Giannoni","year":"2011","journal-title":"Infect. Immun."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/jbmr.3364","article-title":"Estrogen deficiency-mediated M2 macrophage osteoclastogenesis contributes to M1\/M2 ratio alteration in ovariectomized osteoporotic mice","volume":"33","author":"Dou","year":"2017","journal-title":"J. Bone Miner. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"45","DOI":"10.7150\/jca.5044","article-title":"Cystatins in immune system","volume":"4","author":"Magister","year":"2013","journal-title":"J. Cancer"},{"key":"ref_36","first-page":"2977","article-title":"Activation of apoptosis signaling pathways by reactive oxygen species","volume":"1863","year":"2016","journal-title":"BBA\u2014Mol. Cell Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/jor.23138","article-title":"YAP and ERK mediated mechanical strain-induced cell cycle progression through RhoA and cytoskeletal dynamics in rat growth plate chondrocytes","volume":"34","author":"Yang","year":"2016","journal-title":"J. Orthop. Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"202066","DOI":"10.1098\/rsos.202066","article-title":"Geranylgeraniol prevents zoledronic acid-mediated reduction of viable mesenchymal stem cells via induction of Rho-dependent YAP activation","volume":"8","author":"Singhatanadgit","year":"2021","journal-title":"R. Soc. Open Sci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1365-2613.2009.00661.x","article-title":"Ovariectomy-associated changes in bone mineral density and bone marrow haematopoiesis in rats","volume":"90","author":"Lei","year":"2009","journal-title":"Int. J. Exp. Pathol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"11404","DOI":"10.1074\/jbc.275.15.11404","article-title":"Estrogen suppresses transcription of lipoprotein lipase gene: Existence of a unique estrogen response element on the lipoprotein lipase promoter","volume":"275","author":"Homma","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"15161","DOI":"10.1073\/pnas.96.26.15161","article-title":"Estradiol repression of tumor necrosis factor-\u03b1 transcription requires estrogen receptor activation function-2 and is enhanced by coactivators","volume":"96","author":"An","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Dragin, N., Nancy, P., Villegas, J., Roussin, R., Le Panse, R., and Berrih-Aknin, S. (2017). Balance between estrogens and proinflammatory cytokines regulates chemokine production involved in thymic germinal center formation. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-08631-5"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.bcp.2015.11.016","article-title":"Estrogens down-regulate the stem cell factor (SCF)\/c-KIT system in prostate cells: Evidence of antiproliferative and proapoptotic effects","volume":"99","author":"Figueira","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.2147\/DDDT.S103124","article-title":"Zoledronate upregulates MMP-9 and -13 in rat vascular smooth muscle cells by inducing oxidative stress","volume":"10","author":"Arun","year":"2016","journal-title":"Drug Des. Devel Ther."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1210\/en.2011-1439","article-title":"Increased numbers of nonattached osteoclasts after long-term zoledronic acid therapy in mice","volume":"153","author":"Kuroshima","year":"2012","journal-title":"Endocrinology"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/GME.0000000000001568","article-title":"Baseline estrogen levels in postmenopausal women participating in the MAP.3 breast cancer chemoprevention trial","volume":"27","author":"Richardson","year":"2020","journal-title":"Menopause"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Sellitto, A., D\u2019Agostino, Y., Alexandrova, E., Lamberti, J., Pecoraro, G., Memoli, D., Rocco, D., Coviello, E., Giurato, G., and Nassa, G. (2020). Insights into the Role of Estrogen Receptor \u03b2 in Triple-Negative Breast Cancer. Cancers, 12.","DOI":"10.3390\/cancers12061477"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10911-011-9203-7","article-title":"Crosstalk of TGF-\u03b2 and estrogen receptor signaling in breast cancer","volume":"16","author":"Band","year":"2011","journal-title":"J. Mammary Gland. Biol. Neoplasia"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"15192","DOI":"10.1074\/jbc.M212332200","article-title":"Smad4 as a transcription corepressor for estrogen receptor \u03b1","volume":"278","author":"Wu","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Caviness, P.C., Lazarenko, O.P., Blackburn, M.L., Chen, J.F., Randolph, C.E., Zabaleta, J., Zhan, F., and Chen, J.R. (2024). Phenolic acids prevent sex-steroid deficiency-induced bone loss and bone marrow adipogenesis in mice. J. Nutr. Biochem., 127.","DOI":"10.1016\/j.jnutbio.2024.109601"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1096\/fj.201901901R","article-title":"Maternal regulation of SATB2 in osteo-progeniters impairs skeletal development in offspring","volume":"34","author":"Chen","year":"2019","journal-title":"FASEB J."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/5\/833\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:43:30Z","timestamp":1760028210000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/5\/833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,27]]},"references-count":51,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["cancers17050833"],"URL":"https:\/\/doi.org\/10.3390\/cancers17050833","relation":{},"ISSN":["2072-6694"],"issn-type":[{"type":"electronic","value":"2072-6694"}],"subject":[],"published":{"date-parts":[[2025,2,27]]}}}